Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Radiat Oncol Biol Phys ; 38(2): 257-61, 1997 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-9226311

RESUMO

PURPOSE: High-linear energy transfer (LET) radiation beams have potential applications in the treatment of glioblastoma, but have not yet demonstrated significant improvement in results. However, some patients have had local control of glioblastoma with high-LET irradiations such as neutrons and heavy charged particles. METHODS AND MATERIALS: In this collaborative study, 15 patients were entered into a randomized protocol comparing two dose levels of 20 and 25 Gy in 4 weeks of neon ion irradiation. This trial was intended to determine the optimal neon dose in terms of survival and effects of radiation. RESULTS: Fourteen patients were evaluable with no significant differences in median survival (13 and 14 months; p = NS) or median time to failure (7 and 9 months; p = NS) between the two dose arms. Three patients died of nontumor-related causes, of whom one (who died 19 months posttreatment) had autopsy confirmation of no tumor on pathological exam. The other two patients had stable magnetic resonance imaging scans at 6 and 22 months posttreatment. CONCLUSION: Although the results did not demonstrate the optimal high-LET dose level, there is an intriguing effect in that two patients had control of glioblastoma until death at 19 and 22 months. This suggests that better conformation of the high-LET dose to the tumor with neutron capture therapy or dynamic conformal heavy charged particle therapy might control glioblastoma while minimizing brain damage from radiation.


Assuntos
Neoplasias Encefálicas/radioterapia , Glioblastoma/radioterapia , Transferência Linear de Energia , Neônio/uso terapêutico , Adulto , Idoso , Neoplasias Encefálicas/mortalidade , Causas de Morte , Feminino , Glioblastoma/mortalidade , Humanos , Masculino , Pessoa de Meia-Idade
2.
Neurosurgery ; 37(3): 383-90; discussion 390-1, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7501100

RESUMO

This is the first report of a series of adults (> 16 years of age) with pineoblastomas who had their entire neuraxis staged at the time of diagnosis. Between 1975 and 1992, seven men and four women with histologically proven pineoblastomas were evaluated at the University of California, San Francisco. The median age at diagnosis was 36 years (range, 17-59 yr). All patients presented with symptomatic hydrocephalus. One patient had a complete surgical resection, eight had subtotal resections, and two had biopsies only. One patient refused any treatment or follow-up review and died 6 months after diagnosis. The five patients with positively staged disease had progression either focally or in the spine 8 to 49 months (median, 10 mo) after initial diagnosis and died 1 to 20 months after recurrence; the median overall survival time from the date of surgery was 30 months. In contrast, all five patients with negatively staged disease were alive without disease progression after a median of 26 months of follow-up. Our retrospective review shows that the extent of disease at diagnosis seems to be an important prognostic factor for pineoblastomas, as is true for medulloblastomas and other primitive neuroectodermal tumors. Initial staging should include examination of the cerebrospinal fluid and magnetic resonance imaging of the spine. Although patients with pineoblastomas are often treated with adjuvant systemic chemotherapy after craniospinal irradiation, the benefits of this approach are unclear.


Assuntos
Neoplasias Encefálicas/cirurgia , Glândula Pineal/cirurgia , Pinealoma/cirurgia , Adolescente , Adulto , Biópsia , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/mortalidade , Neoplasias Encefálicas/patologia , Diagnóstico Diferencial , Feminino , Seguimentos , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/diagnóstico , Recidiva Local de Neoplasia/mortalidade , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/cirurgia , Estadiamento de Neoplasias , Glândula Pineal/patologia , Pinealoma/diagnóstico , Pinealoma/mortalidade , Pinealoma/patologia , Taxa de Sobrevida
3.
Cancer ; 68(8): 1828-31, 1991 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-1913528

RESUMO

The case of a 57-year-old man with chondrosarcoma of the laryngeal cartilage is presented, occurring 16 years after radiation treatment for squamous cell carcinoma of the right true vocal cord. Chondrosarcoma of the larynx is an uncommon tumor. The location, grade, and time elapsed from initial treatment make it probably that this patient's chondrosarcoma is associated with his prior radiation treatment. However, it is a rare occurrence, this being the second case reported in the literature.


Assuntos
Carcinoma de Células Escamosas/radioterapia , Condrossarcoma/etiologia , Neoplasias Laríngeas/etiologia , Neoplasias Laríngeas/radioterapia , Neoplasias Induzidas por Radiação/etiologia , Segunda Neoplasia Primária , Prega Vocal , Adulto , Humanos , Metástase Linfática , Masculino , Neoplasias do Mediastino/secundário , Pescoço
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA